MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Neuronetics ROE Ratio 2011-2026 | STIM
Annual ROE Ratio Neuronetics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -65.12 | -36.62 | -107.69 | -60.7 | -33.92 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -33.92 | -107.69 | -60.81 |
Quarterly ROE Ratio Neuronetics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -248.31 | -357.46 | -370.9 | -221.4 | -246.15 | -128.69 | -88.75 | -57.29 | -69.37 | -56.7 | -61.15 | -41.46 | -50.41 | -47.28 | -39.79 | -24.42 | -38.77 | -43.23 | -65.94 | -107.69 | -109.13 | -110.07 | -94.44 | -60.7 | -53.56 | -46.19 | -41.92 | -33.92 | -22.72 | -13.79 | -1.75 | 5.99 | 3.44 | 1.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.99 | -370.9 | -86.54 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 3.03 | -2.42 % | $ 98.3 K |  USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.3 | -3.12 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 34.75 | 2.9 % | $ 374 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.34 | -8.84 % | $ 1.7 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.22 | 0.15 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 218.15 | -0.6 % | $ 159 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 102.45 | 0.14 % | $ 19 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.05 | -0.72 % | $ 788 M | USA |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
312.48 | $ 112.47 | 1.8 % | $ 13.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
26.18 | $ 73.19 | -1.09 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.35 | -2.18 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 109.11 | -2.68 % | $ 4.3 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.14 | -1.55 % | $ 288 M | Israel |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.29 | -0.59 % | $ 4.59 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 144.63 | -3.38 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
22.63 | $ 229.55 | -2.52 % | $ 41.6 B | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 11.92 | -3.87 % | $ 1.51 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 209.14 | -1.23 % | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
48.98 | $ 584.25 | -1.49 % | $ 18.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 185.48 | 1.74 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 9.45 | -2.17 % | $ 1.23 B | USA |
 |
Personalis
PSNL
|
-40.05 | $ 9.32 | -6.47 % | $ 552 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
-40.56 | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 269.98 | 0.06 % | $ 22.7 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 380.08 | -0.92 % | $ 29.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 179.68 | -3.34 % | $ 14.8 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 672.01 | -0.69 % | $ 55.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.7 | -1.88 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
22.45 | $ 132.44 | -0.6 % | $ 40.3 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.35 | -1.67 % | $ 5.4 M | USA |